OBJECTIVE To evaluate the usefulness of the LigaSure Precise instrument in superficial lobectomy of the parotid gland. DESIGN Prospective study of the surgical procedures in the LigaSure Vessel Sealing System and comparison with a conventionally treated control group. SETTING Secondary care academic referral center. Patients Thirty-five patients with a parotid gland benign tumor were random...

BACKGROUND Parotid gland metastasis in lung cancer is extremely rare, very few cases have been reported. CASE PRESENTATION We report on the case of a 61-year-old Chinese male patient who presented with parotid swelling metastasizing from advanced lung cancer. We therefore performed an operation of partial parotidectomy with preservation of the facial nerve and advised the patient receive chem...

The patient underwent radical excision of the tumor with a safety margin of 1 cm circumferentially and total parotidectomy, which resulted in a cosmetic defect of the right face that was immediately reconstructed by a local bi-lobed flap (Figure 3). The parotid gland was not involved by tumor. No partial or complete facial dysfunction was noted. The pathological examination revealed a high-grad...

BACKGROUND Salivary duct carcinoma (SDC) is a rare malignancy with a poor prognosis. Human epidermal growth factor receptor-2 (Her-2/neu) is overexpressed in SDC and, hence, HER-2/neu targeted therapy could be an option. METHODS A 72-year-old man presented with parotid swelling and cervical lymphadenopathy. He underwent a parotidectomy, modified radical neck dissection, and postoperative chem...

BACKGROUND: Parotid gland metastasis in breast cancer is extremely rare, and only 14 cases have been reported between 1982 and 2010. CASE REPORT: A 67-year-old female patient was diagnosed with invasive lobular carcinoma of the left breast. Although clinical staging was T1N3M1 (stage IV), the tumor experienced a complete response to chemotherapy. We therefore performed a mastectomy followed by...

Salivary gland cancers are rare and represent approximately 5% of all head and neck cancers and only 0.3% of all malignancies. The majority (75%) of salivary gland tumors occur in the parotid gland, and while benign lesions are more common, mucoepidermoid carcinoma (MEC) makes up 40-50% of malignant parotid gland tumors. No randomized controlled trials exist regarding the role of adjuvant radia...